Entering text into the input field will update the search result below

Vanda Pharma, OliPass collaborate to develop oligonucleotide-based therapeutics

Sep. 29, 2022 5:29 PM ETVanda Pharmaceuticals Inc. (VNDA) StockBy: Anuron Mitra, SA News Editor

Businesspeople making handshake at conference

Klaus Vedfelt

  • Vanda Pharmaceuticals (NASDAQ:VNDA) and South Korea-based biotech OliPass on Thursday said they had entered into a research and development collaboration deal to make antisense oligonucleotide (ASO) therapeutics.
  • ASOs are small pieces of DNA or RNA that can

Recommended For You

More Trending News

About VNDA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VNDA--
Vanda Pharmaceuticals Inc.